CHEK1 and anemia: Elucidation of the role Chk1 plays in erythropoiesis may lead to a better understanding of its possible role in clinically relevant anemias, and will be important in designing therapeutic studies in cancer patients using the new generation of Chk1 inhibitors entering clinical trials.